Nanotechnology makes use of biotechnology

Nanotechnology applications are pushing the boundaries of a number of sectors including electronics. New research in the field of microelectronics facilitates the manufacture of nanodevices at the molecular level based on the use of genetic material.

The EC-funded MINT project focused on the level of interconnections that can be achieved in the new generation of nanodevices. The aim was to achieve at least the same level of interconnections as those in microelectronic systems. Project partners investigated the potential role of ribonucleic acid (RNA) as part of the manufacturing process of original templates.

RNA folds into specific tertiary structures giving researchers the opportunity to exploit this property in order to form new templates for the design of novel nanodevices. Within the framework of MINT, the University of Liverpool designed and characterised a series of self-assembling RNA molecules for the purposes of nanofabrication.

These RNA structures combine either in twos or in fours to form one-dimensional fibres in the presence of magnesium ions. These structures have been designed to facilitate specific and non-specific attachment of RNA molecules to gold nanoparticles, electrodes or surfaces. The resulting RNA-gold fibres have been used successfully as templates for electrochemical deposition of metal on gold surfaces. The aim is to form nanointerconnections between the varied components.

The University is seeking further support to continue this line of research. The applications of this project could have a profound effect on the field of nanotechnology and in particular in the area of nanoelectronics.

Contact Details
BATES, Andy (Dr)
University of Liverpool
Lecturer in Molecular Biology
School of Biological Sciences
L69 7ZB
Liverpool
UNITED KINGDOM
Tel: +44-1517-954563
Fax: +44-1517-954410
URL: http://www.liv.ac.uk/bio/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...

500 Patient Images per Second Shared thr…

The image exchange portal, widely known in the NHS as the IEP, is now being used to share as many as 500 images each second - including x-rays, CT, MRI...

Jane Stephenson Joins SPARK TSL as Chief…

Jane Stephenson has joined SPARK TSL as chief executive as the company looks to establish the benefits of SPARK Fusion with trusts looking for deployable solutions to improve productivity. Stephenson joins...

NIH-Developed AI Algorithm Successfully …

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical research trials...

Heart Attacks could be Ruled Out Early w…

As many as 60% of people presenting to emergency departments around the world with heart attack symptoms could be safely sent home, many at earlier stages, with the support of...

Northern Ireland's Laboratory Servi…

The transformation of pathology services across Northern Ireland has achieved another milestone, with the completion of phase three of the CoreLIMS programme to deploy Clinisys WinPath to all five health...

MEDICA 2024 and COMPAMED 2024: Medical T…

11 - 14 November 2024, Düsseldorf, Germany. "Meet Health. Future. People." is MEDICA's campaign motto for the future in the new trade fair year 2025. The aptness of the motto...

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...